GAMMA Investing LLC Acquires 323 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

GAMMA Investing LLC lifted its holdings in shares of Addus HomeCare Co. (NASDAQ:ADUSFree Report) by 34.5% during the fourth quarter, HoldingsChannel reports. The firm owned 1,258 shares of the company’s stock after purchasing an additional 323 shares during the quarter. GAMMA Investing LLC’s holdings in Addus HomeCare were worth $158,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently made changes to their positions in ADUS. Quarry LP bought a new stake in shares of Addus HomeCare in the 3rd quarter worth approximately $28,000. Quest Partners LLC purchased a new stake in Addus HomeCare in the second quarter worth $31,000. Farther Finance Advisors LLC raised its stake in shares of Addus HomeCare by 9,150.0% in the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after buying an additional 366 shares during the period. Sandia Investment Management LP bought a new stake in shares of Addus HomeCare in the second quarter valued at $58,000. Finally, Assetmark Inc. lifted its position in shares of Addus HomeCare by 11.5% during the 3rd quarter. Assetmark Inc. now owns 1,169 shares of the company’s stock valued at $156,000 after buying an additional 121 shares during the last quarter. 95.35% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

ADUS has been the topic of a number of research reports. JMP Securities began coverage on Addus HomeCare in a research note on Monday, December 16th. They issued an “outperform” rating and a $150.00 price objective on the stock. KeyCorp began coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price target on the stock. Macquarie reaffirmed an “outperform” rating and issued a $139.00 price objective on shares of Addus HomeCare in a report on Monday, November 4th. StockNews.com raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a report on Wednesday, December 11th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $136.00 target price on shares of Addus HomeCare in a research report on Thursday, November 14th. One research analyst has rated the stock with a sell rating, nine have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $133.67.

Get Our Latest Report on ADUS

Addus HomeCare Trading Up 0.6 %

Shares of NASDAQ:ADUS opened at $126.42 on Thursday. Addus HomeCare Co. has a 12-month low of $85.94 and a 12-month high of $136.12. The stock’s 50-day moving average price is $125.00 and its 200-day moving average price is $125.95. The stock has a market capitalization of $2.29 billion, a P/E ratio of 28.93, a price-to-earnings-growth ratio of 2.11 and a beta of 1.00.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last released its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. The firm had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.03 earnings per share. As a group, research analysts predict that Addus HomeCare Co. will post 4.59 EPS for the current year.

Insiders Place Their Bets

In other news, EVP Roberton James Stevenson sold 2,250 shares of the company’s stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the transaction, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,236,257. This represents a 18.05 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO R Dirk Allison sold 25,000 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the sale, the chief executive officer now directly owns 79,397 shares in the company, valued at approximately $9,905,569.72. The trade was a 23.95 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 39,750 shares of company stock worth $4,930,750. 4.60% of the stock is owned by corporate insiders.

About Addus HomeCare

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Featured Stories

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Co. (NASDAQ:ADUSFree Report).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.